|
|
| Línea 1: |
Línea 1: |
| ==Background==
| | #Redirect [[Low Molecular Weight Heparin]] |
| *Trade name = Lovenox
| |
| *A Low Molecular Weight Heparin (LMWH)
| |
| | |
| ==Treatment==
| |
| *DOSE = 1mg/kg sq bid
| |
| *No need to monitor PTT and adjust dosages.
| |
| | |
| ==Uses/Benefits==
| |
| # DVT/PE - equal efficacy
| |
| # Unstable Angina (better than heparin)
| |
| # Ischemic Stroke - (LMWH benefit at 6 months)
| |
| # Prevent prolonged hospitalization
| |
| # Rapid neutralization with protamine possible
| |
| #1:1 mg upto 50 for lovenox in last 8hours
| |
| # Renal insufficiency (creatinine >2), liver disease, pregnancy, or obesity
| |
| | |
| ==Source ==
| |
| 7/2/09 PANI
| |
|
| |
|
| [[Category:Drugs]] | | [[Category:Drugs]] |
| [[Category:Heme/Onc]] | | [[Category:Heme/Onc]] |
